Samsung Electronics has announced results from a clinical study showing that the Galaxy Watch6 can predict vasovagal syncope, commonly known as fainting, up to five minutes before it occurs. The study, conducted jointly with Chung-Ang University Gwangmyeong Hospital in Korea, achieved 84.6% accuracy in predicting fainting episodes, with 90% sensitivity and 64% specificity.
Samsung says the findings represent the world's first successful demonstration of early syncope prediction using a commercial smartwatch. The research was published in Volume 7, Issue 4 of the European Heart Journal – Digital Health.
Galaxy Watch6 Detected Fainting Patterns Before Collapse
The research team, led by Professor Junhwan Cho from the Department of Cardiology at Chung-Ang University Gwangmyeong Hospital, evaluated 132 patients with suspected vasovagal syncope symptoms during induced fainting tests.
Using the Galaxy Watch6's photoplethysmography (PPG) sensor, researchers analysed heart rate variability (HRV) data through an AI-based prediction model. According to Samsung, the system was able to identify signs of an impending fainting episode up to five minutes in advance. Vasovagal syncope occurs when heart rate and blood pressure suddenly drop, often due to factors such as stress, causing temporary loss of consciousness. While fainting itself is generally not life-threatening, sudden falls can lead to secondary injuries, including fractures and concussions.
Professor Cho noted that up to 40% of people experience vasovagal syncope at least once during their lifetime, while roughly one-third face recurrent episodes. Early warnings could allow patients enough time to sit down, move to a safer position, or seek help before losing consciousness.
Samsung Pushes Wearables Beyond Fitness Tracking
Samsung positioned the study as part of a broader shift from reactive healthcare to preventive monitoring through wearable devices.
Jongmin Choi, Head of the Health R&D Group at Samsung's Mobile eXperience Business, said the research demonstrates how wearable technology can move healthcare from "post-care" to "preventive care." The company says it plans to continue expanding health-monitoring capabilities across its wearable portfolio through collaborations with medical institutions. The study's 84.6% accuracy rate, combined with 90% sensitivity, suggests the system is capable of detecting most fainting episodes before they happen. However, the 64% specificity figure also indicates that false positives may occur in some cases, meaning users could occasionally receive warnings even when a fainting episode does not follow.
For users with recurrent vasovagal syncope, however, even a few minutes of advance notice could significantly reduce the risk of injury from sudden falls.
AI Algorithms, Not New Sensors, Are The Real Breakthrough
What stands out in Samsung's research is that the breakthrough does not rely on entirely new hardware. Instead, the study demonstrates how AI models can extract predictive health insights from biometric data already collected by existing smartwatch sensors. The Galaxy Watch6 already uses its PPG sensor for heart rate tracking and other health metrics. Samsung's latest research shows that the same sensor data may also be capable of identifying physiological patterns linked to fainting episodes before they occur. Samsung has not confirmed whether the technology will eventually become a consumer-facing Galaxy Watch feature or remain limited to clinical research validation. The company has also not shared a timeline for potential real-time fainting alerts on future wearable devices.
A subtle but important takeaway here is that Samsung's work highlights where the wearable industry is heading next. Fitness tracking and sleep monitoring have already become standard features across smartwatches, but predictive health alerts could become the next major battleground. If Samsung is eventually able to turn this research into a reliable real-time consumer feature, it could push smartwatches beyond wellness accessories and closer to genuinely preventive health devices.
